Grantclosed🌐 United StatesPAR-24-063

Blueprint Neurotherapeutics Network (BPN): Small Molecule Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)

National Institutes of Health

Details?

Posted: Nov 1, 2023
Response deadline: Nov 17, 2025, 12:00 AM UTC
Type: Grant
Category: 93.866, 93.853, 93.213, 93.279, 93.865, 93.242, 93.867, 93.121, 93.273
Status: closed
Buyer: National Institutes of Health
Department: HHS-NIH11
Jurisdiction: United States
Reference #: PAR-24-063

Doc Type: synopsis
Opp Status: archived

Similar past solicitations

Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (U44 Clinical Trial Optional)
United States · Oct 1, 2024
Development and Application of PET and SPECT Imaging Ligands as Biomarkers for Drug Discovery and for Pathophysiological Studies of CNS Disorders (R01 Clinical Trial Optional)
United States · Nov 6, 2024
NeuroNEXT Small Business Innovation in Clinical Trials (U44 Clinical Trial Optional)
United States · Nov 12, 2024
Clinical Validation of a Candidate Biomarker for Neurological or Neuromuscular Disorders (U44 Clinical Trial Optional)
United States · Jan 22, 2024
Enhancing Blueprint Transformation Network Capacity: Workforce Support and System Development via Clinical Case Mgr
Vermont · May 19, 2026
Enhancing Blueprint Transformation Network Capacity: Workforce Support and System Development through Clinical Knowl
Vermont · May 19, 2026

Finding similar opportunities…

This listing is a summary from United States's open procurement data. We ingest every field the feed publishes; the full solicitation documents are on the source portal.